Edwards Lifesciences Corp at Leerink Global Healthcare Conference Transcript
Thank you all for joining. I'm Mike Cracky. I'm our senior med tech analyst and really thrilled to be joined by, Edwards and CFO Scott Ellen. So Scott, thanks so much for joining us.
Our pleasure. Great to be here. Thanks for having us, Mike.
Great. Well, I'd love to kick things off from your perspective. A lot's happened, but how would you say the business has evolved over the last year? And as you look out over the next 12 months or so, what gets you most excited? Yeah.
It's actually changed a lot over the last year. I mean, in 2025. Maybe I'll start with Taver.
We had this really watershed event, which was.
The presentation in late 2024 of our early TAVR clinical trial data, and it
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
